skip to Main Content
The Heartland Study is the largest study of its kind to look at whether herbicide exposure is impacting pregnancy and child development.

Archived HHRA News Posts
  • Dr. Kimberly Yolton joins HHRA board

    Dr. Yolton is a developmental psychologist and epidemiologist serving as Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center. Her interests include exposures and experiences that may alter a child’s developmental trajectory from infancy through adolescence. She collaborates on research projects on typical child development as well as those focused on the impact of exposures to environmental toxicants, opiates and stress during early development.

  • Paul Hartnett, HHRA’s Executive Director

      Paul Hartnett has served as HHRA’s CFO since our founding . With the departure of Russell King, Paul has now joined the board and Executive Director. We thank Russell for his service and wish him the best in his future endeavors.

  • Heartland Study Enrolls 1,000th Mother-Infant Pair

    July 19, 2024 – In June of this year, the Heartland Study achieved a major milestone, enrolling its 1,000th mother-infant pair. Enrollment is now at 50% of goal. The objective of the Study is to help fill major gaps in our understanding of the impacts of herbicides on maternal and infant health. Currently in Phase 1, the Study is focused on evaluating associations between herbicide concentrations in body fluids and tissue samples from pregnant women and infants, and pregnancy/childbirth outcomes. Phase 2 is designed to evaluate potential associations between herbicide biomarkers and early childhood neurological development. Much appreciation for the mothers enrolled, and the entire Heartland Study Team including scientists, support staff and clinicians for this tremendous achievement, and for our funders to making this work possible. Read more about the study including peer-reviewed studies published in Chemosphere and Agrichemicals at our publications  page. The investment required to conduct this study exceeds $1 million each year. You can support this important work by making a donation here.

  • HHRA’s 2023 Annual Report

    Last year was a year of progress for the HHRA and the Heartland Study. Read about it here!  

  • Supporting HHRA and the Heartland Study Through Donor-Advised Funds

    An increasingly popular way to manage charitable giving is by donating cash, securities, or other assets into a donor-advised fund (DAF), from which you will receive an immediate tax deduction. From this, donors can recommend grants to IRS-qualified nonprofit organizations.  DAFs are one of the easiest and most tax-advantageous ways to “grow” resources earmarked for future charitable giving.  The HHRA is an IRS-qualified organization, and we encourage you to use your DAF, if you have one, to support our mission. You can find three simple steps to supporting our research via your DAF here.  Simple and convenient, your DAF can have genuine effects on the health of mothers, babies, and future generations.  Thank you!

Three Medical Facilities Now Enrolling Women into The Heartland Study

by Rachel Benbrook | Jan 7th, 2021
by Rachel Benbrook | Jan 7th, 2021
The Heartland Study is the largest study of its kind to look at whether herbicide exposure is impacting pregnancy and child development.

Pregnant women in parts of the Midwest can now enroll in our flagship project The Heartland Study to help us understand if rising herbicide exposure is impacting the health of moms and babies.

Moms-to-be can currently enroll at Franciscan Health Hospital and the University of Indiana Medical Center in Indianapolis, IN and at the Gundersen Health System in La Crosse, WI.

We are excited to be underway and enrolling women into The Heartland Study and hope to grow our reach to more partner hospitals in 2021! You can help by donating to support our cutting-edge science.

Back To Top